ID: ALA5171168

Max Phase: Preclinical

Molecular Formula: C19H24ClN5O2S

Molecular Weight: 421.95

Associated Items:

Representations

Canonical SMILES:  CC(=O)Nc1ncc(CN2CCN(CC(=O)Nc3ccc(Cl)cc3)CC2C)s1

Standard InChI:  InChI=1S/C19H24ClN5O2S/c1-13-10-24(12-18(27)23-16-5-3-15(20)4-6-16)7-8-25(13)11-17-9-21-19(28-17)22-14(2)26/h3-6,9,13H,7-8,10-12H2,1-2H3,(H,23,27)(H,21,22,26)

Standard InChI Key:  IILJNGRUWDDWLI-UHFFFAOYSA-N

Associated Targets(Human)

Bifunctional protein NCOAT 460 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Hexosaminidase D 11 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

HT-22 3261 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Brain 4203 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 421.95Molecular Weight (Monoisotopic): 421.1339AlogP: 2.90#Rotatable Bonds: 6
Polar Surface Area: 77.57Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.01CX Basic pKa: 5.85CX LogP: 2.41CX LogD: 2.30
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.75Np Likeness Score: -2.35

References

1. Li X, Han J, Bujaranipalli S, He J, Kim EY, Kim H, Im JH, Cho WJ..  (2022)  Structure-based discovery and development of novel O-GlcNAcase inhibitors for the treatment of Alzheimer's disease.,  238  [PMID:35588599] [10.1016/j.ejmech.2022.114444]

Source